Screener
Ligand Pharmaceuticals LGND Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
FAQ
- What is Ligand Pharmaceuticals's net income?
- Ligand Pharmaceuticals (LGND) reported net income of $48.51M in Q2 2026.
- How has Ligand Pharmaceuticals's net income changed year-over-year?
- Ligand Pharmaceuticals's net income increased by 900.8% year-over-year, from $4.85M to $48.51M.
- What is the long-term trend for Ligand Pharmaceuticals's net income?
- Over 4 years (2021 to 2025), Ligand Pharmaceuticals's net income has grown at a 21.5% compound annual growth rate (CAGR), from $57.14M to $124.45M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Ligand Pharmaceuticals's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude